You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國醫療集團(8225.HK)漲幅擴大至240% 就新型肺炎成立專項行動組
格隆匯 01-29 10:44
格隆匯1月29日丨港股中國醫療集團(8225.HK)漲幅擴大至240.71%,報0.385港元,最新總市值為3.82億港元。中國醫療集團公佈,抗擊冠狀病毒藥品臨牀大數據篩選中心,新型冠狀病毒感染的肺炎疫情暴發,集團成立數字臨牀研究專項行動組,由在抗擊Sars疫情中從事臨牀研究的宋雪梅博士牽頭,與北京大學協和醫學院和武漢同濟大學專家篩選戰勝這次疫情的藥品和開展相應RWS研究。中國醫療集團關聯方萬全萬特廈門製藥公司生產洛匹那韋及利托那韋的口服混懸製劑,國藥準字H20040411:國藥準字H20051019成為衞健委印發新型肺炎國家版診療方案修訂版兩個推薦用藥:抗病毒可試用α-干擾素、洛匹那韋/利托那韋。中療集團RWS臨牀研究中心正在春節期間開展研究。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account